Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ibandronate in Postmenopausal Osteoporosis
NCT01290094Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Started Apr 2011; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01290094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290094.